Loading...
Loading...
Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity.
The trailing-twelve-month return on equity at
Shire plcSHPG is 50.50%. Shire's PEG ratio is 1.01.
The trailing-twelve-month return on equity at
GlaxoSmithKline plc GSK is 50.00%. GlaxoSmithKline's EPS for the same period is $1.69.
The trailing-twelve-month return on equity at
AbbVie Inc. ABBV is 43.50%. AbbVie's revenue for the same period is $19.96 billion.
The trailing-twelve-month return on equity at
Merck & Co. Inc. MRK is 24.80%. Merck's EPS growth forecast for the next year is 12.59%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in